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Introduction
•

•

•

•

Severe acute respiratory
syndrome coronavirus 2 (SARSCoV-2), responsible for causing
coronavirus disease 2019
(COVID-19), has been reported
to cause various neurological
manifestations and long-term
sequelae in individuals following
acute infection.
Many infectious disease
outbreaks throughout history
have resulted neurological
manifestations and postinfectious sequelae, indicating
the importance of the infected
individual’s immune response to
the virus of concern.
Human postmortem brain
studies indicate that human
coronavirus variants and
SARS-CoV can infect neurons and
glia, implying SARS-CoV-2 may
have similar neurovirulence
(Aghagoli et al., 2020), but to
date, the exact neurovirulence of
SARS-CoV-2 remains unknown.
SARS-CoV-2 neuroinvasion is
postulated to be a result of direct
neurotropism and indirect viral
invasion of the Central Nervous
System (CNS) due to a break
down in the Blood-Brain-Barrier
(BBB) (Erikson et al., 2021).

Neuroinvasion, Neurotropic Pathways & Pathophysiological Processes

Reason for Topic
Choice
•

Working as a bedside nurse on a
stroke unit (neurology) at a
comprehensive stroke center has
provided numerous clinical
examples of the direct and
indirect effects of SARS-CoV-2 on
the neurovascular system and is
the reason for choosing this
topic.

Signs & Symptoms

The expression and distribution of Angiotensin Converting Enzyme 2 (ACE2) suggest that SARS-CoV-2 may cause neurological symptoms
through indirect and direct mechanisms (S. Al-Sarraj et al., 2021), as seen in Figure 2 and Figure 3 below (created using Biorender, with credit
for original images cited).

•

•

•

Isolated, sudden anosmia and
ageusia, in the absence of nasal
obstruction or rhinorrhea,
suggests the relevance of early
neurological involvement.
Other neurological clinical
manifestations reported include:
o
Seizure
o
Altered mental status
o
Acute ischemic stroke
o
Ataxia & movement
disorders
o
Dizziness
o
Headaches
o
Demyelinating syndromes
(such as Guillain-Barré)
o
Various psychiatric/
behavioral manifestations
o
long-term neurological

•

•
Figure 1
Host Tissues Known to Express Angiotensin Converting Enzyme 2 (ACE2)
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Indirect
The CNS is impacted by
pathological inflammation
and the cytokine storm that
is triggered outside of the
brain by COVID-19 (Burks et
al., 2021).
Disruption of the BBB
provides a hematogenous
route of entry for SARS-CoV2 to invade the CNS.
Studies have demonstrated
an increase in cytokine
serum levels as a result of
SARS-CoV infection,
consistent with the notion
that cytokine overproduction
and toxicity may be a
relevant potential
mechanism of neurologic
injury, paralleling a known
pathway of pulmonary injury
(Aghagoli et al., 2021; see
Figure 2).
Direct
Multiple non-neuronal cell
types present in the olfactory
epithelium express two host
receptors, ACE2 and TMPRSS2
proteases, that facilitate SARSCoV-2 binding, replication, and
accumulation (Butowt &
Bilinska, 2020).
The olfactory nerve and bulb
serve as a conduit for CNS
infection (Meinhardt et al.,
2021) via neuronal and nonneuronal cells.
Neurotropism: SARS-CoV-2
binds to the angiotensinconverting enzyme 2 (ACE2)
receptor, expressed by neurons
and glial cells (including
astrocytes & microglia; see
Figure 3A)
Microglial reactivity, if initiated
effectively, could orchestrate
the clearance of SARS-CoV-2 in
the CNS or trigger
neuroinflammation (see Figure
3B) and contribute to the
severity of the sequelae
associated with SARS- CoV-2
neurotropism (Awogbindin et
al., 2021).
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•

•

Damage can occur
through the formation
of fibrin
Weakened blood vessels
allow fluid to seep In and
fill the lung cavities,
leading to respiratory
failure

•

Significance of
Pathophysiology

There is ample evidence in literature
(postmortem human brain studies)
suggesting endemic human
coronaviruses infect neurons and glia
(Cevik et al., 2020), but to date, the
neurovirulence of SARS-CoV-2 remains
unknown.
Post-mortem magnetic resonance
imaging (MRI) analysis in COVID-19
patients demonstrated an asymmetry in
olfactory bulb and aberrant brain
parenchyma in 21% of samples thus
further corroborating the relevance of
trans-nasal CNS infection (Coolen et al.,
2020).
Direct neuron infection has potential to
cause future neurodegenerative diseases
in previously infected individuals
(Awogbindin et al., 2021).
Further studies should investigate the
neurovirulence of SARS-CoV-2 and the
future implications of various neurologic
manifestations.

Implications for Nursing Care
Vaccine Hesitancy &
Misinformation
•

•

•
•

Data proves the efficacy and safety
of COVID-19 mRNA vaccines for
individuals 12-years and older in
the United States (US), yet many
are hesitant to get vaccinated, with
67% of unvaccinated adults
believing at least one piece of
misinformation regarding COVID19 vaccination (Altman, 2021).
The unprecedented amount of
misinformation circulating on
social media and cable news
networks indicates a bigger health
literacy problem in the US.
Encourage vaccination in
individuals 12-years and up in
professional and personal life.
See the U.S. Surgeon General’s
advisory on building a healthy
information environment,
Confronting Health Misinformation:

Telemedicine
Considerations
Best practices/standardization is
urgently needed across specialties
and primary care.
Telestroke as a model
Health equity and access should be
considered with telemedicine.

•
•
•

Conclusions
•

•
•

Figure 3- SARS-CoV-2 Neuroinvasion
•
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•

One in twenty people who recover
will experience long COVID.
All healthcare providers that are
in patient-facing roles and clinical
practice should be aware of SARSCoV-2 neurotropism and longterm neurologic sequelae.
Based upon the available evidence
to date, it is crucial for healthcare
providers establish the underlying
mechanisms of action related to
the specific neurological
manifestations that individuals
exhibit in order to prevent
neurological deterioration.
Older adults are at higher risk of
demonstrating neurological
manifestations due to the
processes involved in the
pathophysiological processes
involved with the human brain as
it ages.

•

•

COVID-19 disease includes
neurologic manifestations and
long-term sequelae in some
individuals.
SARS-CoV-2 seems to be a
vasculotropic and neurotropic
virus.
The evidence of a causal
relationship between the SARSCoV-2 virus and autopsy brain
studies remains equivocal (S. AlSarraj et al., 2021).
Further large-scale
molecular/cellular investigations
are needed to clarify
neuropathological correlates with
clinical features since SARS-CoV-2
neurovirulence remains unclear.
Awareness is needed among those
managing SARS-CoV-2-infected
patients with CNS symptoms.
COVID-19 vaccination of more
individuals is needed in the US and
globally; misinformation as a
major barrier in the US.
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